BoneSupport AB - Product Pipeline Analysis, 2019 Update
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; disease or related to surgical procedures. The company develops its bone graft substitutes using its patented technology platform CERAMENT. Its major products include bone void filler and vancomycin-eluting synthetic bone substitute. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and North America. BoneSupport is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; disease or related to surgical procedures. The company develops its bone graft substitutes using its patented technology platform CERAMENT. Its major products include bone void filler and vancomycin-eluting synthetic bone substitute. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and North America. BoneSupport is headquartered in Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
BoneSupport AB Company Overview
BoneSupport AB Company Snapshot
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
BoneSupport AB Pipeline Analysis Overview
Business Description
BoneSupport AB - Key Facts
BoneSupport AB - Major Products and Services
BoneSupport AB Pipeline Products by Development Stage
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB Pipeline Products Overview
CERAMENT + Bisphosphonate
CERAMENT + Bisphosphonate Product Overview
CERAMENT + Bisphosphonates And BMP
CERAMENT + Bisphosphonates And BMP Product Overview
Cerament + BMP
Cerament + BMP Product Overview
CERAMENT + BMP And Stem Cells
CERAMENT + BMP And Stem Cells Product Overview
CERAMENT V
CERAMENT V Product Overview
CERAMENT V Clinical Trial
Cerament|G
Cerament|G Product Overview
Cerament|G Clinical Trial
Gelatin/CERAMENT
Gelatin/CERAMENT Product Overview
BoneSupport AB - Key Competitors
BoneSupport AB - Key Employees
BoneSupport AB - Key Employee Biographies
BoneSupport AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
BoneSupport AB, Recent Developments
May 21, 2019: CERAMENT - Now available exclusively through BONESUPPORT
May 02, 2019: BONESUPPORT HOLDING Published Q1 2019 interim report
Apr 24, 2019: BONESUPPORT - Change in the management team
Apr 10, 2019: Active remodeling of Cerament into human bone confirmed in UK study
Mar 13, 2019: Bonesupport launching a new product - Bonify - US product portfolio expansion
Feb 22, 2019: BONESUPPORT Publication of a clinical study highlighting Vancomycin release from CERAMENT V in major hip surgery
Feb 08, 2019: BONESUPPORT Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT in large bone defects
Feb 01, 2019: BONESUPPORT and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting
Jan 04, 2019: BONESUPPORT appoints Annelie Aava Vikner as executive vice president global marketing & communications
Nov 19, 2018: Bonesupport - positive results from the certify study comparing Cerament |Bone Void Filler with autograft
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview
BoneSupport AB Pipeline Products by Equipment Type
BoneSupport AB Pipeline Products by Indication
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB, Key Facts
BoneSupport AB, Major Products and Services
BoneSupport AB Number of Pipeline Products by Development Stage
BoneSupport AB Pipeline Products Summary by Development Stage
BoneSupport AB Ongoing Clinical Trials by Trial Status
BoneSupport AB Ongoing Clinical Trials Summary
CERAMENT + Bisphosphonate - Product Status
CERAMENT + Bisphosphonate - Product Description
CERAMENT + Bisphosphonates And BMP - Product Status
CERAMENT + Bisphosphonates And BMP - Product Description
Cerament + BMP - Product Status
Cerament + BMP - Product Description
CERAMENT + BMP And Stem Cells - Product Status
CERAMENT + BMP And Stem Cells - Product Description
CERAMENT V - Product Status
CERAMENT V - Product Description
CERAMENT V - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy)
Cerament|G - Product Status
Cerament|G - Product Description
Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures
Cerament|G - CERAMENT lBONE VOID FILLER and Gentamicin Eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients
Cerament|G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis
Cerament|G - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy)
Gelatin/CERAMENT - Product Status
Gelatin/CERAMENT - Product Description
BoneSupport AB, Key Employees
BoneSupport AB, Key Employee Biographies
BoneSupport AB, Subsidiaries
Glossary
List Of Figures
BoneSupport AB Pipeline Products by Equipment Type
BoneSupport AB Pipeline Products by Development Stage
BoneSupport AB Ongoing Clinical Trials by Trial Status
RELATED REPORTS
BoneSupport AB - Product Pipeline Analysis, 2020 Update
BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused
USD 750 View ReportVattenfall AB - Strategy, SWOT and Corporate Finance Report
Vattenfall AB - Strategy, SWOT and Corporate Finance ReportVattenfall AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the
USD 175 View ReportO’Learys Trademark AB - Strategy, SWOT and Corporate Finance Report
OLearys Trademark AB - Strategy, SWOT and Corporate Finance ReportOLearys Trademark AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report
USD 175 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS